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Abstract
 
Leukotriene B
 
4 
 
(LTB
 
4
 
) is a potent chemoattractant active on multiple leukocytes, including
neutrophils, macrophages, and eosinophils, and is implicated in the pathogenesis of a variety of
inflammatory processes. A seven transmembrane–spanning, G protein–coupled receptor, called
BLTR (LTB
 
4
 
 receptor), has recently been identified as an LTB
 
4 
 
receptor. To determine if
BLTR is the sole receptor mediating LTB
 
4
 
-induced leukocyte activation and to determine the
role of LTB
 
4 
 
and BLTR in regulating leukocyte function in inflammation in vivo, we gener-
ated a BLTR-deficient mouse by targeted gene disruption. This mouse reveals that BLTR
alone is responsible for LTB
 
4
 
-mediated leukocyte calcium flux, chemotaxis, and firm adhesion
to endothelium in vivo. Furthermore, despite the apparent functional redundancy with other
chemoattractant–receptor pairs in vitro, LTB
 
4 
 
and BLTR play an important role in the recruit-
ment and/or retention of leukocytes, particularly eosinophils, to the inflamed peritoneum in
vivo. These studies demonstrate that BLTR is the key receptor that mediates LTB
 
4
 
-induced
leukocyte activation and establishes a model to decipher the functional roles of BLTR and
LTB
 
4 
 
in vivo.
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Introduction
 
Leukotrienes are potent biological mediators of inflamma-
tion generated from arachidonic acid via the 5-lipoxygen-
ase pathway (1, 2). Leukotriene B
 
4 
 
(LTB
 
4
 
) primarily me-
diates leukocyte recruitment and activation. LTB
 
4 
 
was
discovered based on its potent chemotactic activity on neu-
trophils (3) but is also active on eosinophils (4, 5). LTB
 
4
 
-
mediated leukocyte recruitment is thought to play a pro-
tective role in host defense against various pathogens.
However, LTB
 
4
 
 is also involved in the pathogenesis of a
wide variety of human inflammatory diseases (1, 2), and
LTB
 
4 
 
receptor(s) therefore represent attractive targets for
therapeutic intervention.
Although chemoattractants constitute a diverse array of
molecules, including lipids, proteins, and peptides, they all
appear to signal leukocytes through a subgroup of the G pro-
tein–coupled, seven transmembrane–spanning family of re-
ceptors. Members of this group of receptors are related in
structure and function and include a receptor for LTB
 
4
 
(BLTR) (6, 7). We previously reported the molecular clon-
ing of murine (m)BLTR while searching for novel chemoat-
tractant receptors expressed in murine eosinophils and dem-
onstrated that it encodes a functional receptor for LTB
 
4 
 
(5).
BLTR function in leukocyte chemoattraction has been
demonstrated in vivo by the ability of synthetic BLTR an-
tagonists to reduce leukocyte recruitment in murine mod-
els of inflammatory diseases (8–10). However, studies of
pharmacologic antagonists may be limited by several fac-
tors, including partial preservation of receptor activity in
the face of the antagonist, difficulty with maintaining an in-
hibitory concentration of the antagonist, and unanticipated
secondary effects of the antagonist administered. Studies of
BLTR antagonists may also be limited by lack of specificity
of these agents for BLTR, as they may modulate other re-
ceptors, including other receptors for LTB
 
4
 
. For example,
LTB
 
4 
 
has been demonstrated to be a natural ligand for the
nuclear receptor peroxisome proliferator-activated receptor
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(PPAR)
 
a
 
 (11). Whereas BLTR appears to mediate the
proinflammatory leukocyte recruitment induced by LTB
 
4
 
,
PPAR
 
a
 
 activation appears to have antiinflammatory ef-
fects, as suggested by the observation of prolonged inflam-
mation in PPAR
 
a
 
-deficient mice when challenged with
LTB
 
4 
 
or its precursor, arachidonic acid (11).
To determine whether BLTR is the sole receptor mediat-
ing LTB
 
4
 
-induced leukocyte recruitment and activation and
whether LTB
 
4 
 
and BLTR play unique roles in inflammation
in vivo, we generated a BLTR-deficient (BLTR
 
2
 
/
 
2
 
) mouse
by targeted gene disruption. Analysis of this mouse reveals that
BLTR alone is responsible for multiple functions involved
in LTB
 
4
 
-mediated leukocyte recruitment: calcium flux,
chemotaxis, and firm adhesion to endothelium in vivo. Fur-
thermore, despite functional redundancy with other chemoat-
tractant–receptor pairs in vitro, LTB
 
4 
 
and BLTR play impor-
tant roles in the recruitment and/or retention of leukocytes,
particularly eosinophils, in a murine model of peritonitis.
 
Materials and Methods
 
Targeted Disruption of the BLTR Gene.
 
An 
 
z
 
16-kb genomic
DNA fragment containing mBLTR was isolated from a 129/SvJ
genomic phage library (Stratagene) using the mBLTR cDNA (5)
as a probe. The BLTR genomic locus was modified by inserting
a neomycin resistance cassette into the open reading frame con-
tained in exon 2, near the proposed initiating methionine. This
construct was introduced into J1 embryonic stem (ES) cells by
electroporation, and transfected cells were selected for neomycin
resistance by addition of the antibiotic G418. Two clones that
showed evidence of homologous recombination by Southern
blotting were injected into blastocysts using standard techniques.
After reimplantation into foster mothers, these clones resulted in
chimeric mice that transmitted the disrupted allele to offspring.
Mice were genotyped by Southern blot and PCR analysis of
DNA extracts from tail snips using standard techniques. In all ex-
periments, BLTR-deficient and control wild-type mice were
generated from matings between heterozygous (BLTR
 
1
 
/
 
2
 
) mice
of similar genetic backgrounds (129/SvJ and C57BL/6 hybrids)
and raised in identical specific pathogen–free conditions.
 
Purification of Mouse Leukocytes.
 
Blood for hematocrits, white
blood cell counts, and differentials was obtained by cardiac punc-
ture. Peritoneal cells were harvested by peritoneal lavage with 10
ml of cold PBS without Ca
 
2
 
1
 
 or Mg
 
2
 
1
 
 (CMF PBS). Intraperito-
neal injections of 1 ml of 3% (wt/vol) thioglycollate broth were
used to elicit inflammatory cells into the peritoneal cavity. Neu-
trophils were harvested 4 h after thioglycollate injection and
macrophages at 96 h. The cellular compositions of lavages were
determined by Diff-Quik–stained (Baxter Scientific) cytocentri-
fuge preparations. Lavages performed 4 h after thioglycollate
contained 
 
z
 
50% neutrophils, whereas lavages performed at 96 h
contained 
 
z
 
80% macrophages. Bone marrow cells were har-
vested by flushing femurs with 5 ml of cold CMF PBS. Bone
marrow neutrophils and mononuclear cells were purified with
Neutrophil Isolation Media-2 (Cardinal Associates).
 
Northern Blot Analysis.
 
RNA was isolated from mouse cells
and organs, and Northern analysis was performed as described (5)
using a [
 
32
 
P]dCTP Klenow-labeled, random-primed mBLTR
cDNA probe and murine glyceraldehyde-3-phosphate dehydrog-
enase (GAPDH) as a control of RNA loading.
 
Calcium Flux.
 
Calcium fluxes in elicited peritoneal neutro-
phils and macrophages in response to the agonists LTB
 
4
 
 and
platelet-activating factor (PAF; Calbiochem) and the murine
chemokines JE, KC, macrophage inflammatory protein (MIP)-
1
 
a
 
, and eotaxin (PeproTech) were determined as described (5).
The data are presented as the relative ratio of fluorescence at 340/
380 nm.
 
Chemotaxis.
 
50 
 
m
 
l of purified mouse bone marrow neutro-
phils at 5.0 
 
3
 
 10
 
6
 
 cells/ml in HBSS were placed in the top of a
48-well modified Boyden microchemotaxis chamber (Neuro-
Probe). 30 
 
m
 
l of 10-fold serial dilutions of LTB
 
4
 
, KC, and FMLP
(formyl-methionine-leucine-phenylalanine; Sigma-Aldrich) in
HBSS were placed in the bottom wells of the chamber and were
separated from the cells by a 3-
 
m
 
m-pore, polyvinylpyrrolidone-
free polycarbonate filter. The apparatus was incubated at 37
 
8
 
C
and 5% CO
 
2
 
 for 60 min, and cells that migrated across the filter
and adhered to the bottom side of the filter were stained with
Diff-Quik and counted.
 
Analysis of Leukocyte Behavior by Intravital Microscopy.
 
Mice
were anesthetized by intraperitoneal injection of 200 
 
m
 
l of saline
containing 15 mg/ml ketamine HCl (Ketaset) and 3 mg/ml xyla-
zine (Phoenix Pharmaceuticals). The right jugular vein was cath-
eterized with polyethylene tubing, and animals were placed on a
Plexiglas stage and the right cremaster muscle (CM) was surgically
prepared and superfused with sterile Ringer’s injection solution as
described (12). Preparations were transferred to an intravital mi-
croscope (Mikron Instruments), and 10 ml/kg saline containing
0.2% rhodamine 6G (Molecular Probes) was injected intrave-
nously to fluorescently label circulating leukocytes, which were
visualized using a 40
 
3
 
 water immersion objective (ZEISS) and
video-triggered stroboscopic epi-illumination as described (12).
1-min recordings of fluorescent cells in venular trees consisting of
two to eight branches (diameter 25 
 
6 
 
8 
 
m
 
m in BLTR
 
1
 
/
 
1
 
 and
28 
 
6
 
 8 
 
m
 
m in BLTR
 
2
 
/
 
2
 
 mice) were made during up to three con-
secutive 5-min intervals (control period). Thereafter, the superfu-
sion buffer was replaced with Ringer’s injection solution contain-
ing 100 nM LTB
 
4
 
. During continuous exposure to LTB
 
4
 
, video
recordings of the same venular tree were made every 5 min for 25
min. Subsequently, the fluorescent plasma marker FITC–dextran,
150 kD (Sigma-Aldrich) was injected intravenously (2 mg per
mouse), and the same venular tree was recorded for measurement
of vascular length and luminal diameter.
Video tapes were analyzed to compare leukocyte behavior at
baseline, i.e., after mild surgical trauma, and during LTB
 
4
 
 superfu-
sion. The total leukocyte flux was determined by counting every
fluorescent cell (rolling plus noninteracting) that passed each
venule per minute. The rolling fraction was calculated by dividing
the flux of rolling cells by the total leukocyte flux. The number of
firmly adherent leukocytes (i.e., cells that remained stationary for
at least 30 s) in the entire venular tree was determined for each
time point. The luminal surface area of venular trees was calcu-
lated by measuring dimensions of FITC–dextran-filled venules,
assuming cylindrical vascular geometry. The number of adherent
leukocytes was divided by the luminal surface area.
 
FACS
 
®
 
 Analysis.
 
Cell suspensions in PBS containing 1% BSA
were preincubated with Fc block (anti-mCD16/32; PharMingen)
or 10% normal mouse serum for 15 min at 4
 
8
 
C before staining
with primary antibodies, including anti-mCCR3 (R&D Systems).
After washing, secondary antibody (FITC–anti–rat IgG2a; Phar-
Mingen) was added to cells labeled with unconjugated primary anti-
bodies for 20 min at 4
 
8
 
C. Cells were then washed, fixed with 2%
paraformaldehyde, and analyzed on a Becton Dickinson FAC-
Scan™ using CELLQuest™ software (Becton Dickinson).
 
Statistical Analysis.
 
Differences in rolling fractions were ana- 
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lyzed by paired Student’s 
 
t
 
 test, and differences in peritoneal lav-
age cell compositions were analyzed by analysis of variance using
Statview
 
®
 
 statistical software (Abacus Concepts, Inc.)
 
Results and Discussion
 
Targeted Disruption of the BLTR Gene.
 
To disrupt the
BLTR gene, a neomycin resistance cassette was inserted
into the open reading frame in exon 2 of BLTR, just 3
 
9
 
 of
the proposed initiating methionine (Fig. 1 A). The fre-
quency of homologous recombination in ES cells was
 
z
 
8.3% (15 of 181 G418-resistant clones). Two ES clones
containing the disrupted allele were injected into blasto-
cysts and resulted in live births after transfer to foster moth-
ers. The chimeras from these clones passed the disrupted al-
lele to their progeny, which were intercrossed to produce
Figure 1. Generation of
BLTR2/2 mice. (A) Schematic
of wild-type locus, targeting
construct, and disrupted allele.
The two exons encoding BLTR
in the wild-type locus are shown
as open boxes. The EcoRI–Hind-
III fragment used as a probe in
Southern blotting is indicated as
a shaded box. This probe identi-
fies a 5-kb fragment of the wild-
type allele upon digestion with
EcoRI. PCR using the primers
BLTR.for and BLTR.rev, lo-
cated as shown, generates a 443-
bp PCR product. The targeting
construct was made by inserting
the 1.85-kb neomycin resis-
tance cassette into the XhoI site
in exon 2, resulting in 2.4 kb of
genomic DNA 59 to the neomy-
cin resistance cassette and 13.6
kb 39 to the cassette. The
EcoRI–HindIII probe identifies
a 3.5-kb fragment of the dis-
rupted allele upon digestion
with EcoRI. PCR using the
primers BLTR.for and neo.rev,
located as shown, generates a
250-bp PCR product from the
disrupted allele. (B) Southern
blot analysis. DNA from wild-
type mice (1/1) and mice het-
erozygous (1/2) or homozy-
gous (2/2) for the disrupted
BLTR allele was digested with
EcoRI and analyzed by South-
ern blotting using the probe in-
dicated in A. Molecular weights
(MW) in kilobases are displayed
on the left of the blot. (C) Ge-
nomic PCR analysis. DNA from
wild-type mice (1/1) and mice
heterozygous (1/2) or ho-
mozygous (2/2) for the dis-
rupted BLTR allele was ana-
lyzed by PCR using the primers
indicated in A. Molecular
weights (MW) in basepairs are
displayed on the left of the gel.
(D) Northern blot analysis. 5 mg
of RNA from neutrophils
(PMN), 10 mg from macro-
phages (MØ), and 20 mg from
lymph nodes (L.N.), lungs, and
spleens of wild-type and BLTR2/2 mice were analyzed by Northern blotting using BLTR cDNA as a probe. The locations of 28S and 18S ribosomal
RNA are displayed on the right of the blot. The previously described 1.45-kb BLTR transcript (solid arrow) was identified in wild-type mice but was
absent in BLTR2/2 mice, being replaced by a larger transcript (dashed arrow). This larger transcript, which resulted from the insertion of the neomycin
resistance cassette in exon 2 of the BLTR gene, was detected at lower levels than the wild-type transcript, which is often seen for hybrid transcripts gen-
erated from gene-targeted alleles. 
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mice homozygous for the disrupted allele. Mice were gen-
otyped by Southern blot analysis of DNA digested with
EcoRI (Fig. 1 B) and confirmed by PCR analysis (Fig.
1 C). The disrupted allele was passed through the germ-
line with a Mendelian inheritance pattern. Homozygous
BLTR
 
2
 
/
 
2
 
 mice were viable, fertile, and without any gross
developmental defects.
To confirm that BLTR expression had been disrupted,
Northern blot analysis was performed with RNA isolated
from neutrophils, macrophages, lymph nodes, lungs, and
spleens of wild-type and homozygous BLTR
 
2
 
/
 
2
 
 mice (Fig.
1 D). This analysis revealed the previously described 1.45-
kb BLTR transcript in wild-type mice. Homozygous gene-
targeted mice did not have this 1.45-kb BLTR transcript
but instead had a larger BLTR mRNA transcript due to
the insertion of the neomycin resistance cassette in exon 2
of the BLTR gene.
 
BLTR Mediates LTB
 
4
 
-induced Calcium Flux in Neutrophils
and Macrophages.
 
Signaling through G protein–coupled,
seven transmembrane–spanning chemoattractant receptors
typically generates a transient rise in intracellular calcium.
We investigated the ability of LTB
 
4 to induce a calcium
flux in thioglycollate-elicited peritoneal neutrophils and
macrophages. LTB4 induced rapid calcium fluxes in both
cell types from wild-type mice but not in either cell type
isolated from BLTR2/2 mice (Fig. 2). In separate experi-
ments, LTB4 at a higher concentration (333 nM) also failed
to induce calcium fluxes in neutrophils from BLTR2/2
mice (data not shown). Additionally, LTB4 induced desen-
sitization in wild-type neutrophils and macrophages, dem-
onstrating normal signaling in these leukocyte preparations.
Calcium flux responses to chemokines KC and MIP-1a
and the lipid chemoattractant PAF were preserved in neu-
trophils from BLTR2/2 mice and were comparable to
those induced in wild-type neutrophils. Similarly, calcium
fluxes in response to the chemokines JE (murine monocyte
chemoattractant protein 1) and MIP-1a as well as PAF in
macrophages from BLTR2/2 mice were comparable to
those induced in wild-type macrophages. Although the re-
sponse of BLTR2/2 macrophages shown in Fig. 2 demon-
strates a minimal calcium flux in response to MIP-1a, this
chemokine produced robust fluxes in these cells in other
experiments (data not shown). These results demonstrate
that BLTR specifically mediates LTB4-induced calcium
flux responses in both neutrophils and macrophages. The
responses of the neutrophil preparations to the neutrophil-
specific chemokine KC but not to the monocyte/mac-
rophage-specific chemokine JE confirmed the presence of
responsive neutrophils in those preparations. Likewise, the
responses of the macrophage preparations to the mono-
cyte/macrophage-specific chemokine JE but not the neu-
trophil-specific chemokine KC confirmed the presence of
responsive macrophages but not neutrophils in those prepa-
rations.
BLTR Mediates LTB4-induced Chemotaxis. As LTB4 is
known to be a potent neutrophil chemoattractant, we in-
vestigated the ability of LTB4 to induce chemotaxis in neu-
trophils isolated from the bone marrow of wild-type
and BLTR2/2 mice. While LTB4 induced a typical dose-
dependent chemotaxis of wild-type neutrophils (peak
chemotaxis at 100 nM), it had no effect on neutrophils iso-
lated from BLTR2/2 mice (Fig. 3). As positive controls,
both FMLP and KC induced comparable chemotaxis of
neutrophils isolated from wild-type and BLTR2/2 mice.
Figure 2. Calcium flux responses of wild-type and BLTR2/2 leukocytes. Each tracing represents the intracellular [Ca21] levels of fura-2–loaded peri-
toneal neutrophils (A) or macrophages (B) measured as relative fluorescence over time. Arrows mark the time of addition of the indicated agonists at op-
timal concentrations: LTB4 (167 nM), JE (20 nM), KC (20 nM), PAF (167 nM), MIP-1a (20 nM), and eotaxin (20 nM). The results shown are repre-
sentative experiments (n 5 3–4 for all cell types).443 Tager et al. Brief Definitive Report
These results demonstrate that BLTR specifically mediates
LTB4-induced neutrophil chemotaxis.
BLTR Mediates LTB4-induced Leukocyte Arrest in CM
Venules. Firm adhesion within blood vessels is a prerequi-
site for leukocyte migration into tissues. In most settings,
rolling leukocytes must encounter a chemotactic stimulus
that triggers rapid activation of integrins, which mediate
firm arrest. Previous intravital microscopy studies have
shown that topically applied LTB4 is a potent inducer of
integrin-mediated arrest of murine leukocytes (12). The
data shown above demonstrate that BLTR is essential for
leukocyte chemotaxis. However, chemotaxis is a slow pro-
cess lasting minutes to hours, whereas integrin-mediated
arrest occurs within seconds or less. Recent studies suggest
that chemoattractant-induced chemotaxis and arrest are
distinct leukocyte functions, suggesting that they are medi-
ated by divergent signaling pathways (13). Thus, it re-
mained to be determined whether BLTR is as essential for
rapid integrin activation as it is for chemotaxis. We per-
formed intravital microscopy to investigate the effect of
BLTR deficiency on LTB4-induced leukocyte arrest in
CM venules of wild-type and BLTR2/2 mice. As shown
previously (12), LTB4 induced a marked accumulation of
adherent leukocytes in wild-type mice in a time-dependent
fashion. In contrast, there was no change in the number of
adherent cells above spontaneous background adhesion in
BLTR2/2 mice (Fig. 4).
It has been well established that chemoattractant-medi-
ated leukocyte arrest must be preceded by selectin-depen-
dent leukocyte rolling (14). To investigate whether BLTR
deficiency affects rolling, we determined rolling fractions in
CM venules. There was no significant difference when
wild-type and BLTR2/2 mice were compared during the
control period (36 6 11% and 41 6 21%, respectively
[mean 6 SD]). LTB4 superfusion did not alter rolling in
BLTR2/2 mice (35 6 15% at 20 min of continuous super-
fusion), but rolling decreased significantly in wild-type
mice (9 6 12% at 20 min; P , 0.05). This decrease in roll-
ing fraction in the presence of a chemotactic stimulus has
been observed previously (14). In all, these data are consis-
tent with a normal response to LTB4 in wild-type mice and
a complete lack of responsiveness in the BLTR2/2 animals.
We conclude that BLTR is not involved in trauma-induced
leukocyte rolling mediated by selectins but that it is essen-
tial for LTB4-induced, rapid, integrin-mediated arrest of
the rolling cells.
Figure 3. Chemotactic responses of wild-type (d) and BLTR2/2 (s) bone marrow neutrophils to LTB4 (A), KC (B), and FMLP (C). Neutrophils
were exposed to increasing concentrations of the indicated chemoattractants in a modified Boyden chamber, and the numbers of cells that migrated
through the membrane were determined. Data are the number of cells per 4003 field (hpf). The results shown are representative experiments (n 5 3)
and presented as the mean of eight fields counted from replicate wells.
Figure 4. Firm adhesion of wild-type and BLTR2/2 leukocytes deter-
mined by intravital microscopy. Fluorescently labeled leukocytes in a rep-
resentative venular tree (consisting of two to eight venular branches) were
videotaped under epifluorescence illumination. Symbols represent the
mean adherent leukocyte density as described in Materials and Methods.
During a 15-min control period, CM preparations were superfused with
sterile bicarbonate–buffered Ringer’s injection solution, and baseline leu-
kocyte adherence was assessed at least once. In some animals, baseline ad-
herence was analyzed three times in 5-min intervals; no spontaneous
changes in baseline rolling or adherence were observed (data not shown).
At time point 0 min, the superfusion buffer was rapidly exchanged for
Ringer’s injection solution containing 100 nM LTB4, and leukocyte ad-
herence was quantitated in the same venular tree at the indicated time
points (n 5 20 venules in four BLTR1/1 mice; n 5 19 venules in three
BLTR2/2 mice)444 LTB4 Receptor–deficient Mice
BLTR Mediates Leukocyte Recruitment in Thioglycollate-
induced Peritonitis. Intraperitoneal instillation of thioglycollate
in wild-type mice induces an inflammatory response that in-
cludes the recruitment of neutrophils, eosinophils, and mac-
rophages. Leukocyte recruitment in this model has been
shown to be at least partially leukotriene dependent in that re-
cruitment is diminished by inhibition of 5-lipoxygenase (15).
We therefore quantified the contribution of BLTR and LTB4
to the in vivo recruitment of neutrophils and eosinophils, for
which LTB4 has potent chemotactic activity, as well as mac-
rophages, which we have previously demonstrated to express
BLTR (5), in this model. Compared with untreated animals,
total peritoneal leukocytes increased 4 h after thioglycollate
instillation, peaked at 48 h, and then declined slightly by 96 h
in both BLTR2/2 and wild-type mice (Fig. 5 A). At 96 h,
BLTR2/2 mice had only 61% as many leukocytes recovered
from the peritoneal cavity as wild-type mice (P , 0.05).
Of the three types of leukocytes recruited, neutrophils,
Figure 5.  Leukocyte recruitment in thioglycollate-
induced peritonitis in wild-type (d) and BLTR2/2 (s)
mice. (A) Total numbers of leukocytes, eosinophils, neu-
trophils, and macrophages are presented as the mean
number of these cells (6SE) obtained by peritoneal lav-
age at baseline and 4, 48, and 96 h after intraperitoneal
injection of thioglycollate in 5–10 mice of each geno-
type. Cell type was determined by morphological analy-
ses of Diff-Quik–stained cytocentrifuge preparations by
an observer blinded to genotype. *P , 0.05; **P , 0.01;
***P , 0.005. (B) Percentages of peritoneal cells attribut-
able to recruited eosinophils were confirmed by flow cy-
tometric analysis at 48 and 96 h after thioglycollate injec-
tion. 25,000 events were analyzed for forward and side
light scatter properties and for expression of mCCR3.
Values represent the percentage of the total cell popula-
tion that falls into the indicated region (R1). The broken
line histogram indicates the isotype control; whereas the
bold line histogram shows mCCR3 staining of the gated
population (R1). These results are representative of four
or five 6–10-wk-old mice of each genotype.445 Tager et al. Brief Definitive Report
eosinophils, and macrophages, the most striking difference
between BLTR2/2 and wild-type mice occurred in eosino-
phil recruitment (Fig. 5 A). Neither group had substan-
tial numbers of peritoneal eosinophils at baseline or 4 h af-
ter thioglycollate instillation. Peak numbers of eosinophils
were seen in both groups at 48 h, but BLTR2/2 mice re-
cruited only 33% as many eosinophils to the inflamed peri-
toneum as wild-type mice at this time point (P , 0.005).
Numbers of peritoneal eosinophils declined in both groups
at 96 h, but BLTR2/2 mice continued to have significantly
fewer of these cells. At 96 h, BLTR2/2 mice had only 20%
as many eosinophils recovered from the peritoneal cavity as
wild-type mice (P , 0.01).
Although the numbers of peritoneal neutrophils and
macrophages appeared lower in the BLTR2/2 mice at
some time points, the differences from wild type did not
reach statistical significance for either of these cell types
(Fig. 5 A).
The marked reduction of eosinophil recruitment to the
inflamed peritoneum after thioglycollate instillation was
confirmed by flow cytometric analysis of leukocytes recov-
ered in peritoneal lavages (Fig. 5 B). CCR3 is the receptor
for the eosinophil-specific chemokine eotaxin, and eosino-
phils were identified by their positive reactivity with anti-
mCCR3 (16) and F4/80 (17) antibodies, their negative
staining with Ly6G (Gr-1) antibody (18), and by their for-
ward and side scatter properties characteristic of granulo-
cytes (gate R1; Fig. 5 B). These flow cytometry markers
used to positively identify eosinophils were validated using
spleen cells from IL-5–transgenic mice (data not shown),
which are composed of 30–50% eosinophils (19). 48 h after
thioglycollate instillation, eosinophils represented 24.1% of
peritoneal cells recovered from wild-type mice but only
13.4% of cells from BLTR2/2 mice as determined by flow
cytometry (Fig. 5 B). In comparison, eosinophils identified
by morphological analysis of Diff-Quik–stained cytocentri-
fuge preparations at this time point accounted for 27.8% of
wild-type peritoneal cells but only 14.2% of BLTR2/2
cells. 96 h after thioglycollate, eosinophils as identified by
flow cytometry represented 12.0% of peritoneal cells re-
covered from wild-type mice but only 2.9% of cells from
BLTR2/2 mice. As determined by morphological analyses
of Diff-Quik–stained cytocentrifuge preparations, eosino-
phils represented 14.2% of wild-type peritoneal cells at this
time point but only 4.6% of BLTR2/2 cells. Thus, at both
48 and 96 h after intraperitoneal injection of thioglycollate,
there were significantly fewer eosinophils recruited to the
inflamed peritoneum in BLTR2/2 mice compared with
wild-type mice, as determined by two different methods,
morphologic analyses of cytospins and flow cytometry,
which gave similar results. Flow cytometry also demon-
strated no difference in the numbers of B cells, T cells, or
NK cells in the peritoneum at 48 or 96 h after thioglycol-
late instillation, as demonstrated by comparable staining
with antibodies to B220, CD3, CD4, CD8, and NK1.1
(data not shown).
Flow cytometric analysis of bone marrow using the same
panel of antibodies as for the peritoneal cells and morpho-
logic analysis of Wright-Giemsa–stained blood smears re-
vealed no differences in leukocyte composition in untreated
BLTR2/2 and wild-type mice in either bone marrow or
blood compartments (data not shown). Additionally, nei-
ther genotype had substantial numbers of eosinophils in the
peritoneal cavity at baseline. Therefore, the decreased num-
bers of eosinophils recovered from BLTR2/2 mice 48 and
96 h after thioglycollate appear attributable to decreased
eosinophil recruitment and/or retention in this model. The
delayed appearance of eosinophils is consistent with their
being recruited by chemoattractants, such as LTB4, pro-
duced by leukocytes preceding the eosinophils into the
peritoneal cavity. The threefold reduction in recruited eo-
sinophils seen in the BLTR2/2 mice at 48 h and the fivefold
reduction seen at 96 h indicates that LTB4 and BLTR play
a dominant role in eosinophil accumulation in the perito-
neum after thioglycollate instillation.
In summary, we have demonstrated that BLTR alone is
responsible for mediating three distinct leukocyte functions
induced by LTB4: calcium flux, chemotaxis, and firm adhe-
sion under flow in vivo. Additionally, in spite of the activ-
ity of multiple chemoattractants upon eosinophils in vitro,
our data demonstrate that loss of BLTR alone is sufficient
to substantially diminish eosinophil recruitment in a mu-
rine model of peritonitis. Studies of other inflammatory
models in the BLTR2/2 mice will give insight into the
roles of LTB4 in human diseases.
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